TARDBP and frontotemporal dementia: Furthermore, TDP-43 aggregates are observed in approximately 50% of frontotemporal dementia (FTD), 30% of AD and 20% of Parkinson’s disease cases, so understanding its toxic mechanism(s) is essential.